3.1. Analysis.
Comparison 3 Patisiran versus placebo in TTR‐FAP, Outcome 1 Disability due to FAP progression (expressed as the change from baseline in the R‐ODS), at 18 months.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.